Sorrow for the Loss of Dr. Sousa

On behalf of the Latin American Society of Interventional Cardiology (SOLACI), We extend our deepest condolences for the departure of our esteemed professor Doctor José Eduardo Morais Rego Sousa, renowned hemodynamist and interventional cardiologist, former Director of the Institute of Cardiology Dante Pazzanese, the Brazilian Society of Interventional Cardiology (SBHCI) and a pillar in the creation of our society, which he successfully chaired between 1996 and 1998. 

Doctor Sousa is known worldwide for diverse outstanding medical innovations, such as the first stenting experiences with conventional stents in humans, a technique he would later perfect with the use of drug eluting stents.  

From SOLACI we join his family and friends in this time of grief, as well as several generations of disciples who learnt this cardiology subspecialty under his wing, following the rigorous example of our unforgettable Doctor Eduardo. May he rest in peace. 

Message from Dr. Aníbal Damonte, President of SOLACI

Message from Dr. Hugo Londero, Former SOLACI President

Message from Dr. Alberto Suárez Nitola, Former SOLACI President

Message from Dr. Jorge Belardi, Former SOLACI President


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....